FDA Says CBD Still Can't Be Dietary Supplement

The agency called on Congress to develop a better regulatory framework for CBD

The U.S. Food and Drug Administration this week announced that it would deny a trio of petitions that requested authorization for cannabidiol (CBD) to be used as a dietary supplement. The agency also advised that Congress needs to establish a better regulatory framework before such a classification is allowed.

Based on existing research and data, the FDA found that the current standards for adding supplements to foods or beverages aren’t sufficient for cannabinoids such as CBD, Reuters reported.

“We have not found adequate evidence to determine how much CBD can be consumed, and for how long, before causing harm,” FDA Principal Deputy Commissioner Janet Woodcock said.

The news reinforces a situation that’s long been apparent for those in the CBD trade: Congress needs to take action before the potential of the market can be fully unleashed.

The issue has been a thorn in the side of hemp and CBD companies for years; the FDA ruled back in 2015 that CBD was not permitted to be used in foods or beverages as a supplement, and it has remained steadfast in that position ever since.

The agency has also been cracking down for years on CBD producers that make health benefit claims or other assertions about their product lines which can’t yet be backed up by solid science, or which have been marketed to kids.

John Schroyer

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

@GreenMarketRpt – 3 hours

Curaleaf Doubles Down on Utah as Medical Market Grows

@GreenMarketRpt – 9 hours

Lowell Farms Posts $24.6 Million Loss for 2022, But CEO Optimistic

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.


By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.